Otto T - Search Results

1

Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma.

Lümmen G, Goepel M, Möllhoff S, Hinke A, Otto T, Rübben H. Lümmen G, et al. Among authors: otto t. J Urol. 1996 Feb;155(2):455-8. J Urol. 1996. PMID: 8558634 Clinical Trial.

2

Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.

Goebell PJ, Otto T, Suhr J, Rübben H. Goebell PJ, et al. Among authors: otto t. J Urol. 2002 Jul;168(1):72-5. J Urol. 2002. PMID: 12050495 Clinical Trial.

3

[Cytokine therapy of metastatic renal cell carcinoma].

Otto T, Goepel M, Luboldt HJ, Rübben H. Otto T, et al. Urologe A. 1995 May;34(3):200-3. Urologe A. 1995. PMID: 7610512 Review. German.

4

A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics.

Krege S, Giani G, Meyer R, Otto T, Rübben H. Krege S, et al. Among authors: otto t. J Urol. 1996 Sep;156(3):962-6. doi: 10.1016/s0022-5347(01)65673-8. J Urol. 1996. PMID: 8709374 Clinical Trial.

5

Management of neurogenic fecal incontinence in myelodysplastic children by a modified continent appendiceal stoma and antegrade colonic enema.

Goepel M, Sperling H, Stöhrer M, Otto T, Rübben H. Goepel M, et al. Among authors: otto t. Urology. 1997 May;49(5):758-61. doi: 10.1016/S0090-4295(96)00623-1. Urology. 1997. PMID: 9145984 Clinical Trial.

6

Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma.

Krege S, Kalund G, Otto T, Goepel M, Rübben H. Krege S, et al. Among authors: otto t. Eur Urol. 1997;31(4):405-7. doi: 10.1159/000474497. Eur Urol. 1997. PMID: 9187898 Clinical Trial.

7

[Therapy with mitomycin C, folic acid and 5-fluorouracil in treatment of metastatic, refractory urinary bladder carcinoma--phase II study].

Otto T, Krege S, Otto B, Goepel M, Rübben H. Otto T, et al. Among authors: otto b. Urologe A. 1997 May;36(3):243-7. doi: 10.1007/s001200050098. Urologe A. 1997. PMID: 9265345 Clinical Trial. German.

8

Phase II trial of titanocene dichloride in advanced renal-cell carcinoma.

Lümmen G, Sperling H, Luboldt H, Otto T, Rübben H. Lümmen G, et al. Among authors: otto t. Cancer Chemother Pharmacol. 1998;42(5):415-7. doi: 10.1007/s002800050838. Cancer Chemother Pharmacol. 1998. PMID: 9771957 Clinical Trial.

9

Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinoma.

Lümmen G, Sperling H, Luboldt H, Otto T, Rübben H. Lümmen G, et al. Among authors: otto t. Urol Int. 1998;61(4):215-9. doi: 10.1159/000030332. Urol Int. 1998. PMID: 10364752 Clinical Trial.

10

Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: a Phase I study.

Otto T, Lümmen G, Kälble T, Recker F, Krege S, Bex A, Noll F, Rübben H. Otto T, et al. Urology. 1999 Sep;54(3):458-60. doi: 10.1016/s0090-4295(99)00154-5. Urology. 1999. PMID: 10475354 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters